These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25024383)

  • 1. Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.
    Michaud HA; SenGupta D; de Mulder M; Deeks SG; Martin JN; Kobie JJ; Sacha JB; Nixon DF
    J Immunol; 2014 Aug; 193(4):1544-8. PubMed ID: 25024383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
    de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
    Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
    J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
    Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
    Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
    Ormsby CE; Sengupta D; Tandon R; Deeks SG; Martin JN; Jones RB; Ostrowski MA; Garrison KE; Vázquez-Pérez JA; Reyes-Terán G; Nixon DF
    PLoS One; 2012; 7(8):e41021. PubMed ID: 22879884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
    Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
    J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
    Jones RB; John VM; Hunter DV; Martin E; Mujib S; Mihajlovic V; Burgers PC; Luider TM; Gyenes G; Sheppard NC; Sengupta D; Tandon R; Yue FY; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    Clin Vaccine Immunol; 2012 Feb; 19(2):288-92. PubMed ID: 22205657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
    Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
    Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell responses to human endogenous retroviruses in HIV-1 infection.
    Garrison KE; Jones RB; Meiklejohn DA; Anwar N; Ndhlovu LC; Chapman JM; Erickson AL; Agrawal A; Spotts G; Hecht FM; Rakoff-Nahoum S; Lenz J; Ostrowski MA; Nixon DF
    PLoS Pathog; 2007 Nov; 3(11):e165. PubMed ID: 17997601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons.
    Lawoko A; Johansson B; Rabinayaran D; Pipkorn R; Blomberg J
    J Med Virol; 2000 Dec; 62(4):435-44. PubMed ID: 11074471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.
    Pollara J; Bonsignori M; Moody MA; Pazgier M; Haynes BF; Ferrari G
    Curr HIV Res; 2013 Jul; 11(5):378-87. PubMed ID: 24191939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.
    Veillette M; Désormeaux A; Medjahed H; Gharsallah NE; Coutu M; Baalwa J; Guan Y; Lewis G; Ferrari G; Hahn BH; Haynes BF; Robinson JE; Kaufmann DE; Bonsignori M; Sodroski J; Finzi A
    J Virol; 2014 Mar; 88(5):2633-44. PubMed ID: 24352444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
    Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
    EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.